IV delafloxacin: Phase III started

In January, Melinta began a double-blind Phase III trial to compare 300 mg IV delafloxacin twice daily for 6 doses followed by 450 mg oral delafloxacin twice daily for up 28 doses vs. 15 mg/kg IV van...